- Home
- GTBP vs SOBR Comparison
GTBP vs SOBR Comparison
Compare GTBP & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- SOBR
- Stock Information
- Founded
- GTBP 1965
- SOBR 2004
- Country
- GTBP United States
- SOBR United States
- Employees
- GTBP N/A
- SOBR N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- SOBR Newspapers/Magazines
- Sector
- GTBP Health Care
- SOBR Consumer Discretionary
- Exchange
- GTBP Nasdaq
- SOBR Nasdaq
- Market Cap
- GTBP 5.5M
- SOBR 5.2M
- IPO Year
- GTBP N/A
- SOBR N/A
- Fundamental
- Price
- GTBP $0.73
- SOBR $3.35
- Analyst Decision
- GTBP Strong Buy
- SOBR
- Analyst Count
- GTBP 1
- SOBR 0
- Target Price
- GTBP $11.00
- SOBR N/A
- AVG Volume (30 Days)
- GTBP 641.6K
- SOBR 15.1K
- Earning Date
- GTBP 11-13-2025
- SOBR 11-13-2025
- Dividend Yield
- GTBP N/A
- SOBR N/A
- EPS Growth
- GTBP N/A
- SOBR N/A
- EPS
- GTBP N/A
- SOBR N/A
- Revenue
- GTBP N/A
- SOBR $301,400.00
- Revenue This Year
- GTBP N/A
- SOBR N/A
- Revenue Next Year
- GTBP N/A
- SOBR N/A
- P/E Ratio
- GTBP N/A
- SOBR N/A
- Revenue Growth
- GTBP N/A
- SOBR 73.21
- 52 Week Low
- GTBP $0.55
- SOBR $2.41
- 52 Week High
- GTBP $4.10
- SOBR $193.50
- Technical
- Relative Strength Index (RSI)
- GTBP 35.99
- SOBR 47.95
- Support Level
- GTBP $0.62
- SOBR $3.18
- Resistance Level
- GTBP $0.68
- SOBR $3.54
- Average True Range (ATR)
- GTBP 0.08
- SOBR 0.13
- MACD
- GTBP 0.03
- SOBR 0.00
- Stochastic Oscillator
- GTBP 45.39
- SOBR 43.59
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.